BRISTOL LABORATORIES

Updated 24 days ago
Private Limited Company
  • Active - 03393503 (CH)
  • Age: 27 years
  • ID: 3524489/158
Bristol House, Unit 3, Canalside, Northbridge Road, Berkhamsted Hertfordshire, HP4 1EG United Kingdom
• 21200 - Manufacture of pharmaceutical preparations
• 46460 - Wholesale of pharmaceutical goods
Established in 1997, Bristol Laboratories is a fast growing British pharmaceutical company engaged in the development, manufacture, marketing and distribution of generic medicines in the UK and Europe... We are delighted to inform you all that Bristol Laboratories Ltd has WON the Hertfordshire Business Awards 2015 for the Large Business of the Year! This award was judged by KPMG for the Most Successful Large Business based in Hertfordshire. They have recognised us as an outstanding business, whose growth, ambition and quality of management... A Hertfordshire-based pharmaceutical company with a manufacturing capacity to produce up to nine billion tablets and capsules a year has hailed a good year as revenues passed the £90m mark. Bristol Laboratories, established in 1997 and based in Berkhamsted, specialises in the development, manufacture, marketing and distribution of generic medicines in the UK and
Also known as: Bristol, BRISTOL LABORATORIES LIMITED, Bristol Laboratories Ltd
Registration numbers: 03393503 (CH)
Primary location: Berkhamsted United Kingdom
Associated domains: allacan.com, allacan.net, bristol-labsconsumercare.co.uk, bristollabs.com
  • 0
  • 0
Interest Score
2
HIT Score
0.50

UK Company Data

Company number
03393503
Account category
FULL
Account ref. day
31
Account ref. month
3
Accounts next due date
2024-12-31
Accounts last made up date
2023-03-31
Returns next due date
2017-07-25
Returns last made up date
2016-06-27
Num. mort. charges
22
Num. mort. outstanding
4
Num. mort. part. satisfied
0
Num. mort. satisfied
18
Num. gen. partners
0
Num. lim. partners
0
Domain
bristol-labs.co.uk

Actual
bristol-labs.co.uk

IP
70.40.220.111

Status
OK

Category
Company, Other
0 comments Add a comment